BioCentury
ARTICLE | Finance

Appetite for white space

Why Lux thinks the time is right to focus on the gut-brain axis

December 21, 2015 8:00 AM UTC

Lux Capital has decided signaling between the gut and brain represents investable white space. The firm led a $44 million series A round last week for Kallyope Inc., which plans to develop therapies that act on the gut-brain axis for metabolic and psychological conditions.

Other investors included Polaris Partners, The Column Group, Illumina Inc. (NASDAQ:ILMN), Tony Evnin and Alexandria Venture Investments. Evnin invested as an individual, not as a partner at Venrock. ...